Blue Cross and Blue Shield of Illinois policy
Rituximab and Biosimilars for Non-Oncologic Indications
Rituximab and Biosimilars for Non-Oncologic Indications is a public Blue Cross and Blue Shield of Illinois policy (policy RX502.030, effective Jan 1, 2026). It lists 5 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
- Policy number
- RX502.030
- Effective
- Jan 1, 2026
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes.
| Code | Other Blue Cross and Blue Shield of Illinois policies |
|---|---|
| J3490 | Policies naming J3490 |
| J9312 | Policies naming J9312 |
| Q5115 | Policies naming Q5115 |
| Q5119 | Policies naming Q5119 |
| Q5123 | Policies naming Q5123 |